Catalyst Wire Dossier Catalyst Wire Dossier

Bilhvax

· INSERM
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bilhvax, covering 2013-08-27 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium [Phase 3]

See pricing